Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H GOSS

Showing results (41-50 of 291) with videos related to

Pageof 30
Sort By:
Contemporary Clinical Trials|August 1, 2006
Respiratory adverse event profiles in cystic fibrosis placebo subjects in short- and long-term inhaled therapy trialsHeidi Sucharew, Christopher H Goss, Steven P Millard, et al.
Paediatric Drugs|August 5, 2017
Comparative Effectiveness Research in Pediatric Respiratory Disease: Promise and PitfallsKathleen J Ramos, Ranjani Somayaji, David P Nichols, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 10, 2015
Association of sweat chloride concentration at time of diagnosis and CFTR genotype with mortality and cystic fibrosis phenotypeEdward F McKone, Priscilla Velentgas, Anna J Swenson, et al.
Biochemistry|May 7, 1985
Purification of biotinidase from human plasma and its activity on biotinyl peptidesD V Craft, N H Goss, N Chandramouli, et al.
Chest|October 14, 2003
The effect of pregnancy on survival in women with cystic fibrosisChristopher H Goss, Gordon D Rubenfeld, Kelly Otto, et al.
American Journal of Respiratory and Critical Care Medicine|August 3, 2002
Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosisChristopher H Goss, Kelly Otto, Moira L Aitken, et al.
Journal of the Pediatric Infectious Diseases Society|September 7, 2022
Drugs, Drugs, Drugs: Current Treatment Paradigms in Cystic Fibrosis Airway InfectionsJonathan D Cogen, David P Nichols, Christopher H Goss, et al.
Advanced Drug Delivery Reviews|November 30, 2002
The cystic fibrosis therapeutics development network (CF TDN): a paradigm of a clinical trials network for genetic and orphan diseasesC H Goss, N Mayer-Hamblett, R A Kronmal, et al.
Critical Care Medicine|June 10, 2003
Incidence of acute lung injury in the United StatesChristopher H Goss, Roy G Brower, Leonard D Hudson, et al.
Journal of STEM Outreach|June 13, 2022
Adapting Pathway Programs to the Virtual World: Insights from the Chicago EYES on Cancer Response to COVID-19-Related Disruptions to TrainingMegan A Mekinda, Michelle L Domecki, Kathleen H Goss, et al.
Pageof 30

Showing results (41-50 of 291) with videos related to

Sort By:
Pageof 30
Contemporary Clinical Trials|August 1, 2006
Respiratory adverse event profiles in cystic fibrosis placebo subjects in short- and long-term inhaled therapy trialsHeidi Sucharew, Christopher H Goss, Steven P Millard, et al.
Paediatric Drugs|August 5, 2017
Comparative Effectiveness Research in Pediatric Respiratory Disease: Promise and PitfallsKathleen J Ramos, Ranjani Somayaji, David P Nichols, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 10, 2015
Association of sweat chloride concentration at time of diagnosis and CFTR genotype with mortality and cystic fibrosis phenotypeEdward F McKone, Priscilla Velentgas, Anna J Swenson, et al.
Biochemistry|May 7, 1985
Purification of biotinidase from human plasma and its activity on biotinyl peptidesD V Craft, N H Goss, N Chandramouli, et al.
Chest|October 14, 2003
The effect of pregnancy on survival in women with cystic fibrosisChristopher H Goss, Gordon D Rubenfeld, Kelly Otto, et al.
American Journal of Respiratory and Critical Care Medicine|August 3, 2002
Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosisChristopher H Goss, Kelly Otto, Moira L Aitken, et al.
Journal of the Pediatric Infectious Diseases Society|September 7, 2022
Drugs, Drugs, Drugs: Current Treatment Paradigms in Cystic Fibrosis Airway InfectionsJonathan D Cogen, David P Nichols, Christopher H Goss, et al.
Advanced Drug Delivery Reviews|November 30, 2002
The cystic fibrosis therapeutics development network (CF TDN): a paradigm of a clinical trials network for genetic and orphan diseasesC H Goss, N Mayer-Hamblett, R A Kronmal, et al.
Critical Care Medicine|June 10, 2003
Incidence of acute lung injury in the United StatesChristopher H Goss, Roy G Brower, Leonard D Hudson, et al.
Journal of STEM Outreach|June 13, 2022
Adapting Pathway Programs to the Virtual World: Insights from the Chicago EYES on Cancer Response to COVID-19-Related Disruptions to TrainingMegan A Mekinda, Michelle L Domecki, Kathleen H Goss, et al.
Pageof 30